1. Academic Validation
  2. Clematichinenoside AR Alleviates Foam Cell Formation and the Inflammatory Response in Ox-LDL-Induced RAW264.7 Cells by Activating Autophagy

Clematichinenoside AR Alleviates Foam Cell Formation and the Inflammatory Response in Ox-LDL-Induced RAW264.7 Cells by Activating Autophagy

  • Inflammation. 2021 Apr;44(2):758-768. doi: 10.1007/s10753-020-01375-x.
Yajing Diao 1
Affiliations

Affiliation

  • 1 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Shandong First Medical University, 16766 Jingshi Road, Jinan, 250014, Shandong Province, China. dyajing0202@163.com.
Abstract

Foam cell formation and inflammation in macrophages contribute to the development of atherosclerosis (AS). Clematichinenoside AR (AR) is a major active ingredient extracted from the traditional Chinese herb Clematis chinensis and has potent pharmacological effects on various diseases, including AS. However, little is known about the exact role and mechanism of AR in AS. RAW264.7 macrophages were exposed to oxidized low-density lipoprotein (ox-LDL) to induce AS in vitro. Cell viability was assessed by the CCK-8 assay. Foam cell formation was detected by Oil Red staining. Cholesterol levels were determined by corresponding commercial kits. The expression of inflammatory cytokines was detected by ELISA. Western blot and immunofluorescence assays were employed to detect the expression of corresponding genes. The results indicated that AR treatment inhibited the formation of foam cells and Cholesterol accumulation but promoted Cholesterol efflux by upregulating ABCA1/ABCG1 in ox-LDL-induced RAW264.7 macrophages. In addition, AR decreased the production of inflammatory cytokines by blunting the activation of the NLRP3 inflammasome and inducing Autophagy. However, these effects of AR were weakened by the Autophagy Inhibitor bafilomycin A1 but were similar to those produced by the Autophagy activator rapamycin. Collectively, our study provides novel insights into the beneficial effects of AR on promoting Cholesterol efflux as well as inhibiting foam cell formation and inflammation by regulating Autophagy, thus identifying AR as a promising therapeutic agent for the treatment of AS.

Keywords

atherosclerosis; autophagy; clematichinenoside AR; foam cell formation; inflammation.

Figures
Products